-
1.发明申请PROCESS FOR THE PREPARATION OF DABIGATRAN ETEXILATE OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF 审中-公开制备DABIGATRAN ETEXILATE或其药学上可接受的盐的方法
公开(公告)号：WO2014049586A2
公开(公告)日：2014-04-03
申请号：PCT/IB2013059017
申请日：2013-09-30
Applicant: RANBAXY LAB LTD
Inventor： VEMPALI ANANDAM , SANWAL SUDHIR SINGH , MURUGESAN BALAGURU , SATHYANARAYANA SWARGAM , THAPER RAJESH KUMAR , PRASAD MOHAN
IPC: C07D401/12
CPC classification number: C07D401/12 , C07C303/32
Abstract: The present invention provides hydrobromide salt of dabigatran etexilate and its process for the preparation. The present invention further provides crystalline Form I and crystalline Form II of hydrobromide salt of dabigatran etexilate and processes for their preparation. The present invention further relates to a process for the preparation of pharmaceutically acceptable salts, including methanesulfonate salt, of dabigatran etexilate using hydrobromide salt of dabigatran etexilate of the present invention.
Abstract translation: 本发明提供达比加群酯的氢溴酸盐及其制备方法。 本发明还提供了达比加群酯的氢溴酸盐的晶型I和结晶形式II及其制备方法。 本发明还涉及使用本发明的达比加群酯的氢溴酸盐制备达比加群酯的药学上可接受的盐，包括甲磺酸盐的方法。
-
Patent Agency Ranking
公开(公告)号：WO2011033472A1
公开(公告)日：2011-03-24
申请号：PCT/IB2010054196
申请日：2010-09-16
Applicant: RANBAXY LAB LTD , SANWAL SUDHIR SINGH , KUMAR SARIDI MADHAVA DILEEP , SATHYANARAYANA SWARGAM , THAPER RAJESH KUMAR , PRASAD MOHAN
Inventor： SANWAL SUDHIR SINGH , KUMAR SARIDI MADHAVA DILEEP , SATHYANARAYANA SWARGAM , THAPER RAJESH KUMAR , PRASAD MOHAN
IPC: C07D403/06
CPC classification number: C07D403/06
Abstract: The present invention relates to salts of sunitinib and their preparation.
Abstract translation: 本发明涉及舒尼替尼的盐及其制备方法。
-
3.发明申请CRYSTALLINE FORMS OF DABIGATRAN ETEXILATE AND PROCESS FOR THEIR PREPARATION 审中-公开DABIGATRAN ETEXILATE的结晶形式及其制备方法
公开(公告)号：WO2014020546A3
公开(公告)日：2014-03-27
申请号：PCT/IB2013056266
申请日：2013-07-30
Applicant: RANBAXY LAB LTD
Inventor： MURUGESAN BALAGURU , SANWAL SUDHIR SINGH , VEMAPLI ANANDAM , SATHYANARAYANA SWARGAM , THAPER RAJESH KUMAR , PRASAD MOHAN
IPC: C07D401/12 , A61K31/4439 , A61P7/02
CPC classification number: C07D401/12
Abstract: The present invention relates to crystalline Form 1, Form 2, Form 3, and Form 4 of dabigatran etexilate, and processes for their preparation. The present invention further relates to processes for the preparation of a dabigatran etexilate methanesulfonate salt using crystalline Form 1, Form 2, Form 3, and Form 4 of dabigatran etexilate.
Abstract translation: 本发明涉及达比加群酯的结晶形式1，形式2，形式3和形式4及其制备方法。 本发明还涉及使用达比加群酯的结晶形式1，形式2，形式3和形式4制备达比加群酯甲磺酸盐的方法。
-
4.发明申请PROCESS FOR THE PREPARATION OF CRYSTALLINE FORM I OF L-MALIC ACID SALT OF SUNITINIB 审中-公开制备太尼丁L-肉豆蔻酸盐结晶形式I的方法
公开(公告)号：WO2011058521A4
公开(公告)日：2011-09-01
申请号：PCT/IB2010055150
申请日：2010-11-12
Applicant: RANBAXY LAB LTD , SANWAL SUDHIR SINGH , KUMAR SARIDI MADHAVA DILEEP , SATHYANARAYANA SWARGAM , THAPER RAJESH KUMAR , PRASAD MOHAN
Inventor： SANWAL SUDHIR SINGH , KUMAR SARIDI MADHAVA DILEEP , SATHYANARAYANA SWARGAM , THAPER RAJESH KUMAR , PRASAD MOHAN
IPC: C07D403/06
CPC classification number: C07D403/06
Abstract: The present invention relates to a process for the preparation of crystalline Form I of the L-malic acid salt of sunitinib.
Abstract translation: 本发明涉及制备舒尼替尼的L-苹果酸盐的结晶形式I的方法。
-
5.发明申请PROCESS FOR THE PREPARATION OF DABIGATRAN ETEXILATE OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF 审中-公开制备DABIGATRAN ETEXILATE或其药学上可接受的盐的方法
公开(公告)号：WO2014049585A2
公开(公告)日：2014-04-03
申请号：PCT/IB2013059016
申请日：2013-09-30
Applicant: RANBAXY LAB LTD
Inventor： VEMPALI ANANDAM , SANWAL SUDHIR SINGH , MURUGESAN BALAGURU , SATHYANARAYANA SWARGAM , THAPER RAJESH KUMAR , PRASAD MOHAN
IPC: C07D401/12
CPC classification number: C07D401/12 , C07C53/10 , C07C53/48 , C07C309/19 , C07D213/75
Abstract: The present invention relates to a process for the preparation of dabigatran etexilate. The present invention also relates to trifluoroacetate salt of dabigatran etexilate and a process for its preparation. The present invention further relates to crystalline Form I and crystalline Form II of trifluoroacetate salt of dabigatran etexilate and processes for their preparation. The present invention further relates to a process for the preparation of pharmaceutically acceptable salts, including methanesulfonate salt, of dabigatran etexilate.
Abstract translation: 本发明涉及制备达比加群酯的方法。 本发明还涉及达比加群酯的三氟乙酸盐及其制备方法。 本发明还涉及达比加群酯的三氟乙酸盐的晶型I和结晶形式II及其制备方法。 本发明还涉及制备达比加群酯的药学上可接受的盐，包括甲磺酸盐的方法。
-
6.发明申请PROCESS FOR THE PREPARATION OF CRYSTALLINE FORM I OF L-MALIC ACID SALT OF SUNITINIB 审中-公开制备硫酸铵的结晶形式I的方法
公开(公告)号：WO2011058521A3
公开(公告)日：2011-07-07
申请号：PCT/IB2010055150
申请日：2010-11-12
Applicant: RANBAXY LAB LTD , SANWAL SUDHIR SINGH , KUMAR SARIDI MADHAVA DILEEP , SATHYANARAYANA SWARGAM , THAPER RAJESH KUMAR , PRASAD MOHAN
Inventor： SANWAL SUDHIR SINGH , KUMAR SARIDI MADHAVA DILEEP , SATHYANARAYANA SWARGAM , THAPER RAJESH KUMAR , PRASAD MOHAN
IPC: C07D403/06
CPC classification number: C07D403/06
Abstract: The present invention relates to a process for the preparation of crystalline Form I of the L-malic acid salt of sunitinib.
Abstract translation: 本发明涉及一种制备舒尼替尼的L-苹果酸盐的晶型I的方法。
-
-
-
-
-
Search Results
6
records
(took 0.015 seconds)
